3651 results for «211»

Filter By

3651 results

Best companion's case on coronary complications

22 May 2025 – From EuroPCR 2025

This session showcases expert cases addressing coronary complications during PCI, including novel optimization approaches, managing intervention challenges under pressure, unconventional staged PCI strategies, and decision-making in high-risk scenarios to improve procedural safety and outcomes.

Best companion's case on coronary complications

Best companions's case on complications in calcified lesions

22 May 2025 – From EuroPCR 2025

Delve into challenging cases involving complications in calcified coronary lesions managed with rotational atherectomy. Topics include unique uses of Rotablation, managing burr entrapment, complex calcium and tortuosity combinations, and addressing perforations resulting from stent optimization and burr retrieval in highly calcified vessels.

Best companions's case on complications in calcified lesions

Peripheral expertise to the rescue

22 May 2025 – From EuroPCR 2025

This session addresses peripheral vascular expertise in managing access complications and occlusions. Learn about approaches to femoral access challenges during TAVI, endovascular solutions for iatrogenic hepatic artery rupture, and unconventional treatments for superficial femoral artery occlusions caused by covered stents.

Peripheral expertise to the rescue

Through decisions in complex left main PCI – Left main trifurcation

22 May 2025 – From EuroPCR 2025

This session offers an in-depth analysis of complex left main trifurcation PCI, covering evaluation through imaging and physiology, lesion preparation strategies, and treatment options including stepwise provisional approaches, upfront two-stent techniques, and drug-coated balloons.

Through decisions in complex left main PCI – Left main trifurcation

Extensive anterior STEMI - Treatment strategies from SCAI A to E

22 May 2025 – From EuroPCR 2025

Explore comprehensive treatment strategies for extensive anterior STEMI, focusing on risk stratification across the SCAI shock stages A to E. Learn to adapt mechanical circulatory support appropriately and understand principles guiding device selection and utilization in hemodynamic instability.

Extensive anterior STEMI - Treatment strategies from SCAI A to E

Intracoronary imaging guidance for PCI

22 May 2025 – From EuroPCR 2025

This session highlights the value of intracoronary imaging guidance for PCI, showcasing optical coherence tomography in complex ACS lesions, long-term outcomes from imaging-guided PCI trials, AI-enhanced quantification, and comparative analyses of intravascular lithotripsy versus rotational atherectomy.

Intracoronary imaging guidance for PCI

Assessment and management of patients with multivalvular disease involving the tricuspid valve

22 May 2025 – From EuroPCR 2025

Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.

Assessment and management of patients with multivalvular disease involving the tricuspid valve

Role of coronary physiology in acute coronary syndrome patients

22 May 2025 – From EuroPCR 2025

Examine the role of coronary physiology in acute coronary syndrome patients, including plaque characteristics related to ACS risk, prognostic value of AngioIMR in STEMI, functional significance of lumen and plaque features, diagnostic accuracy of quantitative flow ratio, and the impact of adenosine administration routes on FFR...

Role of coronary physiology in acute coronary syndrome patients

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART
Didn’t find what you were looking for?